REVB · Revelation Biosciences, Inc.
$1.14
+0.02 (+1.79%)
At close · Aug 7
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company does not anticipate that its current cash and cash equivalents balance will be sufficient to sustain operations within one year after the date that the Company's unaudited condensed financial statements for June 30, 2026 were issued, which raises substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$4.54M
Shares
3.98M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding REVB
2 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | — | 42,373 | $46,610 | 0.00% | Long | 2026-05-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 50 | $60 | 0.00% | Long | 2026-03-31 |
Showing 1–2 of 2 positions